Cannabis

Indiva records strong edibles growth

Demand for Indiva Limited’s edible products continues to rise with record gains in December 2020

MORE THAN ONE out of every three edibles sold in the key cannabis markets of B.C., Alberta and Ontario during the month of December was made by local cannabis producer Indiva Limited — a record for the company, who have come to occupy a dominant position in the Canadian edibles market.

Last week, the company circulated data from market data firm Hifyre that showed impressive performances in those provincial markets, where they held more than 40 per cent market share in each.

“Edibles are one of the fastest growing categories in the cannabis market, and Indiva is committed to continuing to leverage the experience and innovation of our licensing partners to bring new edible products to market to support further growth” Niel Marotta

“We are delighted that customers and clients continue to support Indiva’s core edible brands in market, as evidenced by market share gains at the retail level,” Niel Marotta, Indiva’s CEO, stated in a press release. “The improvement in market share is particularly encouraging given the backdrop of new entrants into the category.”

This is the latest in positive reports for the company. The Indiva’s third quarter results, released late last year, reported quarterly revenues of $3.42 million — a 22 per cent increase from the previous quarter.

Story Continues Below

 

A key aspect of this strong performance is the company’s strength in the two major edibles categories of chocolates and gummies, where their Bhang Chocolate and Wana Sour Gummies brands each lead, respectively. To put this into context, according to the company’s data one of every four edibles sold in Canada was one of Indiva’s sour gummies.

“Edibles are one of the fastest growing categories in the cannabis market, and Indiva is committed to continuing to leverage the experience and innovation of our licensing partners to bring new edible products to market to support further growth,” says Marotta.

The company’s positive outlook is also based on last year’s news that they had reached an agreement to supply Shoppers Drug Mart’s medical cannabis market, and preliminary revenues for the month of October in which the comp

any recorded record revenues. Profitability remained elusive, however, with the company reporting another $3.5 million loss overall. But as costs in raw cannabis materials continues to decrease, the company hopes to see improvements in their margins into this year. Kieran Delamont

Recent Posts

The 2026 view from Gen Z

Gen Z: They’re stalled, stressed and scanning the horizon for more bad news in the coming year

15 hours ago

The holiday hideout

Devoid of porch pirates, snoopy spouses and missed deliveries, the office has become the go-to depot for everyone’s holiday shopping

1 day ago

What are the odds?

Someone has finally calculated the odds of an online application actually resulting in a job. It’s about as bad as…

3 days ago

Minimum deposit, maximum control: Smart payment strategies for low-budget Canadian players

Canadians are choosing low-deposit strategies to help keep discretionary entertainment spending in control

3 days ago

Job prospects looking bleak? Not if you’re in the corner office

Despite a job market that is increasingly challenging for most jobseekers, executive roles abound

3 days ago

The glue that holds the team together

Motivated by progress, not attention, glue employees may be more valuable to high-performing teams than their star talent

3 days ago